These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1972362)

  • 21. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
    Pérez HA; De la Rora M
    Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
    [No Abstract]   [Full Text] [Related]  

  • 22. Variants with reduced virulence derived from Leishmania major after mutagen treatment.
    Marchand M; Daoud S; Titus RG; Louis J; Boon T
    Parasite Immunol; 1987 Jan; 9(1):81-92. PubMed ID: 3562060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice.
    Heinzel FP; Sadick MD; Locksley RM
    Exp Parasitol; 1988 Apr; 65(2):258-68. PubMed ID: 3127233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.
    Hill JO; Awwad M; North RJ
    J Exp Med; 1989 May; 169(5):1819-27. PubMed ID: 2523955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY; Singleton A; Cillari E; Howard JG
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis.
    Wang ZE; Reiner SL; Hatam F; Heinzel FP; Bouvier J; Turck CW; Locksley RM
    J Immunol; 1993 Aug; 151(4):2077-86. PubMed ID: 8102158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence.
    da Fonseca AL; Vallochi AL; Furtado Gde C; Abrahamsohn Ide A; Lima GM
    Parasitol Res; 1997; 83(7):690-7. PubMed ID: 9272560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
    Scott P; Natovitz P; Coffman RL; Pearce E; Sher A
    J Exp Med; 1988 Nov; 168(5):1675-84. PubMed ID: 2903212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major.
    Mitchell GF; Handman E; Spithill TW
    Int J Parasitol; 1985 Dec; 15(6):677-84. PubMed ID: 4093239
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunization of susceptible BALB/c mice against Leishmania braziliensis. I. Resistance induced using as immunogen adherent or nonadherent cells from infected mice.
    Gorczynski RM
    Cell Immunol; 1985 Aug; 94(1):1-10. PubMed ID: 3160485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.
    Titus RG; Marchand M; Boon T; Louis JA
    Parasite Immunol; 1985 Sep; 7(5):545-55. PubMed ID: 3877902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M; Bahrami F; Niknam HM
    PLoS One; 2018; 13(9):e0204491. PubMed ID: 30248142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
    Sadick MD; Heinzel FP; Holaday BJ; Pu RT; Dawkins RS; Locksley RM
    J Exp Med; 1990 Jan; 171(1):115-27. PubMed ID: 2104918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro assessment of anti-Leishmania immunity of man acquired with a vaccine.
    Vouldoukis I; Ogunkolade BW; Frommel D; Alier N; Monjour L
    Experientia; 1988 Jan; 44(1):56-7. PubMed ID: 3350121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.
    Kahl LP; Lelchuk R; Scott CA; Beesley J
    Infect Immun; 1990 Oct; 58(10):3233-41. PubMed ID: 2401562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.